New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines
Authors:
Open Access
Abstract
For research and development to systematically deliver fairly priced medicines, new approaches to financing and organisation are needed, and affordability must be integrated into push, pull, and pooling mechanisms, say Fatima Suleman and colleaguesKeywords
This publication has 8 references indexed in Scilit:
- New business models for research and development with affordability requirements are needed to achieve fair pricing of medicinesBMJ, 2020
- Essential medicines for universal health coverageThe Lancet, 2017
- Vouching for accessNature Medicine, 2016
- A systematic review and critical assessment of incentive strategies for discovery and development of novel antibioticsThe Journal of Antibiotics, 2015
- A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health ImportancePLOS Medicine, 2015
- What Is the Public’s Right to Access Medical Discoveries Based on Federally Funded Research?JAMA, 2014
- Securing the public good of health research and development for developing countriesBulletin of the World Health Organization, 2012
- The critical impact of time discounting on economic incentives to overcome the antibiotic market failureNature Reviews Drug Discovery, 2012